| |
|
|
|
PLx Pharma Inc.  
|
|
3.84 -0.16 (-0.04%) |
12-13 09:30 |
|
Open: |
3.82 |
Pre close: |
4 |
Target:
|
4.84
|
|
High: |
3.84 |
Low: |
3.84 |
Resistance:
|
4.14
4.47
|
|
Volume: |
207 |
Market Cap: |
34M |
Support:
|
3.61
3.00
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.90
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
4.10 |
Signal(12,26,9): |
0.04 |
|
MA(100): |
3.80 |
Stochastic Oscillator |
%K(14,3):
|
3.98  |
|
MA(250): |
4.61 |
%D(3): |
4.14 |
|
Average Volume(K) |
3-Month: |
480
|
52-Week |
High:
|
7.60 |
|
10-Days: |
297 |
Low: |
3.05 |
|
RSI |
RSI(14):
|
42.23 |
Change(%): |
-44.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.570 |
Return on Equity (ttm) |
-127.2 |
Shares Out. (M) |
8.74 |
|
EPS Est. Current Year |
-1.610 |
Return on Assets (ttm) |
-34.6 |
Shares Float (M) |
4.28 |
|
EPS Est. Next Year |
-1.820 |
PEG Ratio |
-0.16 |
% Held by Insiders |
51.20 |
|
EPS Est. Next Quarter |
-0.460 |
Qtrly Rev. Growth |
247.8 |
% Held by Institutions |
25.50 |
|
Forward EPS |
-1.350 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
10.570 |
EBITDA (p.s.) |
0.000 |
P/E |
-2.45 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.36 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-12.91 |
P/S |
372906656.00 |
|
Operating Margin |
-1545.34 |
Levered Free Cash Flow
(M) |
-9.78 |
P/CF |
-2.60 |
|
|
|
|
|
|
